NCT05323799View on ClinicalTrials.gov

The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
COVID-19
Trial Locations (1)

3004

The Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne

All Listed Sponsors
lead

Macfarlane Burnet Institute for Medical Research and Public Health Ltd

OTHER

NCT05323799 - The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise) | Biotech Hunter | Biotech Hunter